MedTherapy
MedTherapy Biotech is a Boston-based global Cancer Cell & Gene Therapy company founded in 2018 by experts from Harvard and former Novartis executives. It is an end-to-end, integrated CAR-T Cell CDMO with a commercial scale GMP manufacturing facility in New Delhi, India, and a technology development site in Boston, USA. The company's mission is to make cancer gene therapy accessible and affordable for all cancer patients worldwide, leveraging innovative technologies to reduce manufacturing time and costs, and expanding capacity through global GMP-grade facilities. MedTherapy offers comprehensive services including manufacturing CAR-T cell therapies, viral vectors, clinical development, analytical services, and regulatory support. It is committed to ethical conduct, transparency, and fostering a culture of innovation and responsibility.
Industries
Nr. of Employees
small (1-50)
MedTherapy
1250 Hancock Street, Suite 803N, Quincy, Massachusetts, USA 02169
Products
Proprietary platform technologies for vector and CAR-T manufacturing
Integrated platform technologies that combine vector production and CAR-T manufacturing workflows to reduce manufacturing time and cost and enable scalable production.
Proprietary platform technologies for vector and CAR-T manufacturing
Integrated platform technologies that combine vector production and CAR-T manufacturing workflows to reduce manufacturing time and cost and enable scalable production.
Services
Contract development and manufacturing services for CAR-T cell therapies, including platform implementation (open/closed/modular), automation options, cGMP manufacturing and scale-up to commercial volumes.
GMP-grade production of viral vectors (lentiviral, retroviral, AAV) and associated development work including stable cell line production and scale-up for use as raw material in cell and gene therapies.
Services to support clinical development of cell and gene therapies including clinical trial execution and clinical-scale manufacturing under cGMP.
Analytical testing and manufacturing analytics to support quality control, release testing and process monitoring for cell and gene therapy products.
Regulatory planning and dossier preparation, inspection support, query response and post-approval lifecycle management for global markets.
Contract development and manufacturing services for CAR-T cell therapies, including platform implementation (open/closed/modular), automation options, cGMP manufacturing and scale-up to commercial volumes.
GMP-grade production of viral vectors (lentiviral, retroviral, AAV) and associated development work including stable cell line production and scale-up for use as raw material in cell and gene therapies.
Services to support clinical development of cell and gene therapies including clinical trial execution and clinical-scale manufacturing under cGMP.
Analytical testing and manufacturing analytics to support quality control, release testing and process monitoring for cell and gene therapy products.
Regulatory planning and dossier preparation, inspection support, query response and post-approval lifecycle management for global markets.
Expertise Areas
- Viral vector manufacturing
- CAR-T cell therapy manufacturing
- Clinical trial management for cell & gene therapies
- cGMP facility operations
Key Technologies
- Lentiviral vector production
- Retroviral vector production
- Adeno-associated virus (AAV) production
- Stable producer/packaging cell lines